Balloul; Jean-Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Balloul; Jean-Marc.The latest application filed is for "immortalized avian cell lines and use thereof".

Company Profile

0.17.12

Balloul; Jean-Marc - Strasbourg FR
Balloul; Jean-Marc - Illkirch Graffenstaden Cedex N/A FR
Balloul; Jean-Marc - Lingolsheim FR
Balloul; Jean-Marc - Lille FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Avian telomerase reverse transcriptase Grant 9,024,003 - Erbs , et al. May 5, 2	2015-05-05
Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines Grant 8,932,599 - Guillet , et al. January 13, 2	2015-01-13
Immortalized avian cell lines and use thereof Grant 8,778,675 - Balloul , et al. July 15, 2	2014-07-15
Immortalized Avian Cell Lines And Use Thereof App 20130236929 - Balloul; Jean-Marc ; et al.	2013-09-12
Immortalized avian cell lines and use thereof Grant 8,445,270 - Balloul , et al. May 21, 2	2013-05-21
Papillomavirus vaccines Grant 8,420,103 - Baudin , et al. April 16, 2	2013-04-16
Immortalized Avian Cell Lines And Use Thereof App 20120122155 - BALLOUL; Jean-Marc ; et al.	2012-05-17
Immortalized Avian Cell Lines And Use Thereof App 20110212488 - BALLOUL; Jean-Marc ; et al.	2011-09-01
Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines App 20110171250 - Guillet; Jean-Gerard ; et al.	2011-07-14
Avian Telomerase Reverse Transciptase App 20100173378 - Erbs; Philippe ; et al.	2010-07-08
Papillomavirus Vaccines App 20100143408 - Baudin; Martine ; et al.	2010-06-10
Pharmaceutical compositions for treating papillomavirus tumors and infection Grant 7,670,607 - Balloul , et al. March 2, 2	2010-03-02
Pharmaceutical Compositions For Treating Papillomavirus Tumors And Infection App 20090104156 - Balloul; Jean-Marc ; et al.	2009-04-23
Pharmaceutical compositions for treating papillomavirus tumors and infection Grant 7,488,482 - Balloul , et al. February 10, 2	2009-02-10
Poxvirus with targeted infection specificity Grant 7,354,591 - Balloul , et al. April 8, 2	2008-04-08
Poxvirus with targeted infection specificity Grant 7,348,014 - Balloul , et al. March 25, 2	2008-03-25
Antitumoral composition based on immunogenic polypeptide with modified cell location Grant 7,332,478 - Kieny , et al. February 19, 2	2008-02-19
Pharmaceutical compositions for treating papillomavirus tumors and infection App 20070065459 - Balloul; Jean-Marc ; et al.	2007-03-22
Pharmaceutical composition for treating papillomavirus tumors and infection Grant 7,118,754 - Balloul , et al. October 10, 2	2006-10-10
Combination products for use in antitumoral treatment App 20050245471 - Balloul, Jean-Marc ; et al.	2005-11-03
Poxvirus with targeted infection specificity App 20050208074 - Balloul, Jean Marc ; et al.	2005-09-22
Antitumoral composition based on immunogenic polypeptide with modified cell location App 20050159386 - Kieny, Marie-Paule ; et al.	2005-07-21
Antitumoral composition based on immunogenic polypeptide with modified cell location Grant 6,884,786 - Kieny , et al. April 26, 2	2005-04-26
Poxvirus with targeted infection specificity App 20030165477 - Balloul, Jean-Marc ; et al.	2003-09-04
Protein recognized by antibodies raised against native P28 of schistosoma mansoni Grant 5,597,570 - Sondermeyer , et al. January 28, 1	1997-01-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.